Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Total Liabilities 2020–2025
Moleculin Biotech Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Moleculin Biotech Inc. total liabilities as of December 31, 2025: 7.1M, a 34.95% decrease year-over-year.
- Moleculin Biotech Inc. total liabilities for 2025 were 7.1M, a 34.95% decrease from 2024.
- Moleculin Biotech Inc. total liabilities for 2024 were 10.9M, a 9.86% decrease from 2023.
- Moleculin Biotech Inc. total liabilities for 2023 were 12.1M, a 132.15% increase from 2022.
- Moleculin Biotech Inc. total liabilities for 2022 were 5.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Moleculin Biotech Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $11 |
| 2023 | $12 |
| 2022 | $5 |
| 2021 | $5 |
| 2020 | $11 |
Moleculin Biotech Inc. Total Liabilities — FAQ
Moleculin Biotech Inc. (MBRX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBRX's total liabilities history?
The chart and table above show Moleculin Biotech Inc.'s total liabilities by year and by quarter, including the growth rate.